AI-generated summary
The authors systematically reviewed four randomized controlled trials of low-level laser therapy in patients with sub-acute Bell's palsy, comprising 171 patients in total. Two trials reported significant differences between groups after six weeks of 830 nm laser, while two others found no effectiveness. The authors state there is a clear lack of information for an evidence-based suggestion, though the six-week 830 nm protocol might be beneficial.
- Participants
- 171
- Studies included
- 4
- Who or what was studied
- Patients with sub-acute Bell's palsy (less than 1 week since onset)
- Wavelengths
- 830, 670 nm
- Limits stated in the abstract
- The authors state there is a clear lack of information, the evidence is limited to four trials, and results conflict between studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 100 mW
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Systematic review, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.